Latest filing published 13 Jun 2025 for Adicet Bio, Inc.. Read the official filing
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
This profile gathers the share dealings of Andrew Sinclair across 3 companies, led by Adicet Bio, Inc., Soleno Therapeutics Inc and Sierra Oncology, Inc. The record holds 10 filings, for trades running from 8 December 2021 to 11 June 2025.
The open-market record is one-sided, with 3 purchases worth €12.4M and not one sale. No amount is published for 1 filing, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 6 share grants.
The record was last updated on 13 June 2025 with a share grant in Adicet Bio, Inc. The last insider purchase was made public on 31 March 2022, 1,662 days ago. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations